EVEROLIMUS IN THE TREATMENT FOR METASTATIC RENAL CANCER

Target drugs acting via the HIF/VEGF pathway show a steady-state clinical effect in treating patients with metastatic renal cell carcinoma (RCC). However, to continue therapy in patients with developing resistance in the prolonged use of tyrosine kinase inhibitors remained unsolved, which brought ab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: B. Ya. Alekseyev, A. S. Kalpinsky
Formato: Artigo
Idioma:Russo
Publicado em: ABV-press 2010-09-01
Colecção:Onkourologiâ
Assuntos:
renal cell carcinoma
tyrosine kinase inhibitors
mtor inhibitors
everolimus
overall and relapse-free survival
effectiveness
Acesso em linha:https://oncourology.abvpress.ru/oncur/article/view/279
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados